Found: 10
Select item for more details and to access through your institution.
Processing of Endogenous AβPP in Blood-Brain Barrier Endothelial Cells is Modulated by Liver-X Receptor Agonists and Altered Cellular Cholesterol Homeostasis.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 27, n. 2, p. 341, doi. 10.3233/JAD-2011-110854
- By:
- Publication type:
- Article
Processing of endogenous AβPP in blood-brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV–negative volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 66, n. 4, p. 508, doi. 10.1111/j.1365-2125.2008.03214.x
- By:
- Publication type:
- Article
Adipose triglyceride lipase affects triacylglycerol metabolism at brain barriers.
- Published in:
- Journal of Neurochemistry, 2011, v. 119, n. 5, p. 1016, doi. 10.1111/j.1471-4159.2011.07498.x
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine.
- Published in:
- Clinical Pharmacokinetics, 2009, v. 48, n. 9, p. 561
- By:
- Publication type:
- Article
Clinical pharmacokinetics and pharmacodynamics of etravirine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Steady-State Pharmacokinetics of Etravirine and Lopinavir/Ritonavir Melt Extrusion Formulation, Alone and in Combination, in Healthy HIV-Negative Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 2, p. 202, doi. 10.1177/0091270012445205
- By:
- Publication type:
- Article
Effects of Different Meal Compositions and Fasted State on the Oral Bioavailability of Etravirine.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 10, p. 1215
- By:
- Publication type:
- Article
Safety, Tolerability, and Preliminary Efficacy of 48 Weeks of Etravirine Therapy in a Phase IIb Dose-Ranging Study Involving Treatment-Experienced Patients with HIV-1 Infection.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 7, p. 969, doi. 10.1086/591705
- By:
- Publication type:
- Article